Preview
Unable to display preview. Download preview PDF.
Références
(1997) TNM Classification of Malignant Tumors. 152–156. L.H. Sobin (Editor), Ch. Wittekind Editor. Ref Type: Serial (Book, Monograph)
Pecorelli S, Zigliani L, Odicino Fe (2001) Cancer of the ovary and fallopian tube. In: Goasparowicz MK, Henson DE, Hutter RVP, Sobin LH, Wittekind Ch, editors. New York: Wiley-Liss (UICC Second Edition): 531
Negishi H, Takeda M, Fujimoto T et al. (2004) Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol 94(1): 161–6
Petru E, Lahousen M, Tamussino K et al. (1994) Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 170(2): 656–62
Vergote I, De W, I, Tjalma W et al. (1998) Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol 71(3): 431–6
Morice P, Joulie F, Camatte S et al. (2003) Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg 197(2): 198–205
Le T, Adolph A, Krepart GV et al. (2002) The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 85(2): 351–5
Meier WJ (2000) Lymphadenectomy in stage I ovarian cancer. ASCO Proceedings 19
Sakurai S (2002) Validity of complete paraaortic and pelvic lymphadenectomy in apparent stage I (pT1) ovarian carcinoma. ASCO Proceedings 21
Suzuki M, Ohwada M, Yamada T et al. (2000) Lymph node metastasis in stage I epithelial ovarian cancer. Gynecol Oncol 79(2): 305–8
di Re F, Baiocchi G, Fontanelli R et al. (1996) Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer: prognostic significance of node metastases. Gynecol Oncol 62(3): 360–5
Faught W, Le T, Fung Kee FM et al. (2003) Early ovarian cancer: what is the staging impact of retroperitoneal node sampling? J Obstet Gynaecol Can 25(1): 18–21
Zinzindohoue C, Lujan R, Boulet S et al. (2005) La lymphadénectomie lombo aortique et pelvienne dans les cancers épithéliaux de l’ovaire. A propos d’une série de 86 cas. Ann Chir 125: 163–72
NIH consensus conference (1995) Ovarian cancer. Screening, treatment and follow-up. NIH Consensus Development Panel on Ovarian Cancer. JAMA 273(6): 491–7
Makar AP, Baekelandt M, Trope CG et al. (1995) The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer. Gynecol Oncol 56(2): 175–80
Tingulstad S, Skjeldestad FE, Halvorsen TB et al. (2003) Survival and prognostic factors in patients with ovarian cancer. Obstet Gynecol 101(5 Pt 1): 885–91
van der Burg ME, van Lent M, Buyse M et al. (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 332(10): 629–34
Burghardt E, Pickel H, Lahousen M et al. (1986) Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol 155(2): 315–9
Onda T, Yoshikawa H, Yokota H et al. (1996) Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma. A proposal for essential sites for lymph node biopsy. Cancer 78(4): 803–8
Spirtos NM, Gross GM, Freddo JL et al. (1995) Cytoreductive surgery in advanced epithelial cancer of the ovary: the impact of aortic and pelvic lymphadenectomy. Gynecol Oncol 56(3): 345–52
Rouvière. Livre d’ Anatomie
Burke TN (1992) Selective pelvic and paraaortic lymphadenectomy. Op.Tech.Gyn.Surg 1, 17–21. Ref Type: Journal (Full)
Burghardt E, Girardi F, Lahousen M et al. (1991) Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol 40(2): 103–6
Tangjitgamol S, Manusirivithaya S, Sheanakul C et al. (2003) Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma? Int J Gynecol Cancer 13(3): 297–302
Scarabelli C, Gallo A, Visentin MC et al. (1997) Systematic pelvic and para-aortic lymphadenectomy in advanced ovarian cancer patients with no residual intraperitoneal disease. Int J Gynecol Cancer 7(1): 18–26
Wu PC, Qu JY, Lang JH et al. (1986) Lymph node metastasis of ovarian cancer: a preliminary survey of 74 cases of lymphadenectomy. Am J Obstet Gynecol 155(5): 1103–8
Drieskens O, Stroobants S, Gysen M et al. (2003) Positron emission tomography with FDG in the detection of peritoneal and retroperitoneal metastases of ovarian cancer. Gynecol Obstet Invest 55(3): 130–4
Huglo D, Vinatier D (2004) [Utilization of PET scan in breast and gynaecologic cancers]. Gynecol Obstet Fertil 32(4): 330–9
Yoshida Y, Kurokawa T, Kawahara K et al. (2004) Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer. AJR Am J Roentgenol 182(1): 227–33
Leblanc E, Querleu D, Narducci F et al. (2000) Surgical staging of early invasive epithelial ovarian tumors. Semin Surg Oncol 19(1): 36–41
Tozzi R, Kohler C, Ferrara A et al. (2004) Laparoscopic treatment of early ovarian cancer: surgical and survival outcomes. Gynecol Oncol 93(1): 199–203
Joulie F, Morice P, Rey A et al. (2004) [Are nodal metastases in ovarian cancer chemoresistant lesions? Comparative study of initial lymphadenectomy or after chemotherapy]. Gynecol Obstet Fertil 32(6): 502–7
Kimball RE, Schlaerth JB, Kute TE et al. (1997) Flow cytometric analysis of lymph node metastases in advanced ovarian cancer: clinical and biologic significance. Am J Obstet Gynecol 176(6): 1319–26
Trimbos JB, Vergote I, Bolis G et al. (2003) Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst 95(2): 113–25
Childers JM, Hatch KD, Tran AN et al. (1993) Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol 82(5): 741–7
Possover M, Krause N, Plaul K et al. (1998) Laparoscopic para-aortic and pelvic lymphadenectomy: experience with 150 patients and review of the literature. Gynecol Oncol 71(1): 19–28
Benedetti-Panici P, Maneschi F, Cutillo G et al. (1997) A randomized study comparing retroperitoneal drainage with no drainage after lymphadenectomy in gynecologic malignancies. Gynecol Oncol 65(3): 478–82
Lopes AD, Hall JR, Monaghan JM (1995) Drainage following radical hysterectomy and pelvic lymphadenectomy: dogma or need? Obstet Gynecol 86(6): 960–3
Giannice R, Susini T, Ferrandina G et al. (2001) Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer 92(10): 2562–8
Gol M, Saygili U, Saatli B et al. (2004) Should advanced age alone be considered a contraindication to systemic lymphadenectomy in gynecologic oncologic patients? A university hospital experience in Turkey. Int J Gynecol Cancer 14(3): 508–14
(1998) Tumeurs malignes de l’ovaire: Standars options et recommandations. FNCLCC, editor. Editions John Libbey Eurotext. Ref Type: Serial (Book, Monograph)
Benjamin I, Morgan MA, Rubin SC (1999) Occult bilateral involvement in stage I epithelial ovarian cancer. Gynecol Oncol 72(3): 288–91
Junor E (2000) The impact of specialist training for surgery in ovarian cancer. Int J Gynecol Cancer 10(S1): 16–8
Saygili U, Guclu S, Uslu T et al. (2002) Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG Study. J Surg Oncol 81(3): 132–7
Rights and permissions
Copyright information
© 2006 Springer-Verlag France
About this chapter
Cite this chapter
Bobin, JY., Schneider, M. (2006). Place du curage ganglionnaire lombo-aortique et pelvien dans les cancers épithéliaux de l’ovaire. In: Les cancers ovariens. Abord clinique. Springer, Paris. https://doi.org/10.1007/2-287-30921-7_16
Download citation
DOI: https://doi.org/10.1007/2-287-30921-7_16
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-25168-9
Online ISBN: 978-2-287-30921-2